ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2023

Tissue-Engineered Disease Modeling of Lymphangioleiomyomatosis Exposes a Therapeutic Vulnerability to HDAC Inhibition.

Adam Pietrobon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.